全部

1·CR test can be used to monitor the anticoagulant effect of LMWH.

CR值有可能成为LMWH抗凝活性的床旁检测指标。

2·Objective To explore thrombolysis action of low molecular weight heparin (LMWH).

目的探讨低分子肝素(L MWH)的溶栓作用。

3·LMWH is efficacious, safe and simple for the treatment of acute cerebral infarction.

低分子肝素治疗急性脑梗死是有效、安全、简便的。

4·International Circulation: Which LMWH would you normally choose to use in ACS patients?

《国际循环》：对ACS患者通常你会选择使用哪种低分子量肝素？

5·Result: LMWH was better than common heparin in treating ACS patients, the complications of LMWH is less.

结果：低分子肝素疗效优于普通肝素，且并发症少。

6·Methods: Patients were randomly divided into LMWH plus aspirin treatment group and aspirin control group.

方法：病人被随机分成低分子肝素加阿斯匹林治疗组和阿斯匹林对照组。

7·Purpose To study purification method of the low molecular weight heparin(LMWH) by affinity chromatography.

目的探索亲和色谱纯化低分子肝素的方法。

8·Conclution: Early administration of LMWH in UA can improve the prognosis and reduce the incidence of adverse.

结论：早期应用LMWH治疗UA可以改善预后，降低副反应的发生率。

9·The control group received LMWH, insulin therapy, on this basis, combined with the observation group PE treatment.

对照组采取LMWH、胰岛素治疗，在此基础上，观察组联合PE治疗。

10·AIM: To study the effect and safety of low-molecular-weight heparin (LMWH) in the treatment of acute ischemic stroke.

目的：评价低分子肝素(LMWH)治疗急性缺血性中风的疗效和安全性。